← All Gazelle Parent, INC filings

Gazelle Parent, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
OBX
Gazelle Parent, INC
SCHEDULE: Deep Track Capital Discloses 5.37% Stake in Obsidian Therapeutics
Deep Track Capital, along with affiliated entities, has reported beneficial ownership of 5.37% of Obsidian Therapeutics' common stock as of August 11, 2026.
NASDAQ
OBX
Gazelle Parent, INC
SCHEDULE: Atlas Venture Funds Disclose Obsidian Therapeutics Stake
Multiple Atlas Venture funds have collectively reported beneficial ownership of 7.3% of Obsidian Therapeutics, Inc. common stock as of August 3, 2026.
NASDAQ
OBX
Gazelle Parent, INC
SCHEDULE: RA Capital Discloses 9.7% Stake in Obsidian Therapeutics
RA Capital Management and its affiliates have reported beneficial ownership of 9.7% of Obsidian Therapeutics' common stock as of August 3, 2026.
NASDAQ
OBX
Gazelle Parent, INC
SCHEDULE: Novo Holdings A/S Acquires 5.1% Stake in Obsidian Therapeutics
Novo Holdings A/S has reported acquiring a 5.1% stake in Obsidian Therapeutics, Inc., signaling a notable investment from a major life sciences focused firm.